Pharming (ADR) (PHAR)
Commercializes rare-disease medicines while advancing a mitochondrial-disease program.
$11.21
At close+0.08 (+0.72%)
Something off on this page? Send us feedback.
Breakdown13F · 13D/G · Form 4
| Institutions18 holders · as of Jun 30, 2026 | 3.20% | 2.24M ADS |
institutions as of Jun 30, 2026 · holders as of their latest filing
No reliable share count is available for this listing, so stakes are shown as shares, not percentages.
The institutional percentage is the one reported with the filings, not one recomputed on the share count here.
Institutions13F, as of Jun 30, 2026
18 holders · 2.24M shares · 8 new positions · 11 increased · 6 reduced · 3 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Mac Alpha Capital Management, LP | 2.15M | +2.15Mnew | Aug 14, 2026 | |
| Silverberg Bernstein Capital Management LLC | 41.5K | −3.2K | Jul 7, 2026 | |
| Crossmark Global Holdings, Inc. | 12.5K | +12.5Knew | Jul 16, 2026 | |
| Citadel Advisors LLC | 12.0K | +1.8K | Aug 14, 2026 | |
| Morgan Stanley | 11.5K | +11 | Aug 13, 2026 | |
| Smartharvest Portfolios, LLC | 10.4K | −382 | Aug 4, 2026 | |
| Knoll Capital Management, LLC | 4.1K | +34 | Aug 14, 2026 | |
| Silver Grove Financial Group, Inc. | 1.1K | +1.1Knew | Aug 13, 2026 |
Ownership statements13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Morgan Stanley | 6.50% | 44.16M | Nov 8, 2024 ↗ |
Insider tradesForm 4
Latest trades
Nothing filed in the last 12 months.
CongressHouse and Senate disclosures
Not reported.